 SAN DIEGO, July 21, 2022 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2022, after the market close on Thursday, August 4, 2022. Ron Rocca, Exagens President and Chief Executive Officer, Kamal Adawi, Chief Financial Officer, and Mark Hazeltine, Chief Operating Officer, will host a conference call to review the Companys results at 4:30 PM ET 1:30 PM PT. 